Jeffrey W. Sherman, M.D., FACP
2020
Compensation breakdown
| Non-Equity Incentive Plan | $881,977 |
|---|---|
| Salary | $578,731 |
| Stock Awards | $3,708,048 |
| Other | $92,545 |
| Total | $5,261,300 |
FACP received $3.7M in stock awards, accounting for 70% of the total pay in 2020.
FACP also received $882K in non-equity incentive plan, $578.7K in salary and $92.5K in other compensation.
Rankings
In 2020, Jeffrey W. Sherman, M.D., FACP's compensation ranked 2,075th out of 13,090 executives tracked by ExecPay. In other words, FACP earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,075 out of 13,090 | 84th |
Division Manufacturing | 798 out of 5,621 | 86th |
Major group Chemicals And Allied Products | 286 out of 2,254 | 87th |
Industry group Drugs | 242 out of 1,954 | 88th |
Industry Pharmaceutical Preparations | 171 out of 1,459 | 88th |
Pay ratio
| Jeffrey W. Sherman, M.D., FACP's Pay | $5,261,300 |
|---|---|
| Median Employee's Pay | $298,446 |
| Pay Ratio | 18to 1 |
In 2020, the annual total compensation of Jeffrey W. Sherman, M.D., FACP was $5,261,300.
The annual total compensation of the median employee at Horizon Pharma was $298,446.
The ratio of Jeffrey W. Sherman, M.D., FACP's pay to the pay of median employee was therefore 18 to one.
FACP's colleagues
We found five more compensation records of executives who worked with Jeffrey W. Sherman, M.D., FACP at Horizon Pharma in 2020.
2020
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2020
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2020
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
2020
Barry Moze
Horizon Pharma
Chief Administrative Officer
2020
Brian Beeler
Horizon Pharma
General Counsel
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019